Definitive Healthcare Corp.

NASDAQ:DH

3.74 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 59.19162.28862.69763.73763.4865.93265.32560.95759.20160.59957.38254.54850.12446.31343.08439.82136.93633.65830.07327.29327.293
Cost of Revenue 15.43114.68613.66622.69222.4222.44811.89511.16811.9069.7959.72411.77811.32810.89810.4859.8699.4378.3147.4132.6292.629
Gross Profit 43.7647.60249.03141.04541.0643.48453.4349.78947.29550.80447.65842.7738.79635.41532.59929.95227.49925.34422.6624.66524.665
Gross Profit Ratio 0.7390.7640.7820.6440.6470.660.8180.8170.7990.8380.8310.7840.7740.7650.7570.7520.7450.7530.7530.9040.904
Reseach & Development Expenses 9.3018.9827.28210.12210.13211.56910.75910.2299.88410.1299.2058.7066.855.7484.7464.2773.7943.4962.6182.4742.474
General & Administrative Expenses 12.2698.50311.35412.52716.88316.56714.54513.6713.6415.21713.7189.39210.45411.6377.886.3754.6364.8222.5382.7842.784
Selling & Marketing Expenses 20.65320.37220.1321.54521.7623.60522.80424.70223.42323.52321.18423.58521.29317.38414.37612.88411.74310.798.2927.6257.625
SG&A 32.92228.87531.48434.07238.64340.17237.34938.37237.06338.7434.90232.97731.74729.02122.25619.25916.37915.61210.8310.40910.409
Other Expenses 186.323109.308235.63241.62.64-1.98229.589-0.7979.5910.0410.0374.0029.8749.8659.76-0.10.12410.1610.11200
Operating Expenses 228.546147.165274.39844.19448.77551.74157.90358.28956.53758.90954.14451.87748.47144.63436.76233.14429.61929.26823.5627.94127.941
Operating Income -184.786-99.563-225.367-3.149-7.715-8.257-295.378-12.071-12.94-7.298-0.958-11.214-9.776-12.174-4.026-6.623-2.158-6.952-0.94-2.923-2.923
Operating Income Ratio -3.122-1.598-3.595-0.049-0.122-0.125-4.522-0.198-0.219-0.12-0.017-0.206-0.195-0.263-0.093-0.166-0.058-0.207-0.031-0.107-0.107
Total Other Income Expenses Net 18.8078.95123.81941.5542.751-2.10729.156-1.018-4.411-0.6763.6931.422-1.985-1.915-16.94-8.416-8.33-8.91-9.022-9.39-9.39
Income Before Tax -165.979-90.612-201.548-328.087-13.498-12.187-266.222-13.089-16.31-10.309-6.369-9.792-12.97-14.089-20.966-15.039-10.488-15.862-9.962-12.667-12.667
Income Before Tax Ratio -2.804-1.455-3.215-5.148-0.213-0.185-4.075-0.215-0.276-0.17-0.111-0.18-0.259-0.304-0.487-0.378-0.284-0.471-0.331-0.464-0.464
Income Tax Expense -10.886-5.895-13.724-21.9-0.781.175-17.534-1.484-0.71-17.044-0.015-0.2130.0870.675-5.1728.2168.5788.6889.022-25.3330
Net Income -107.228-59.075-130.896-213.635-9.518-10.233-171.526-8.566-15.66.735-6.354-5.15-13.057-9.699-15.794-15.039-10.488-15.862-9.96212.667-12.667
Net Income Ratio -1.812-0.948-2.088-3.352-0.15-0.155-2.626-0.141-0.2640.111-0.111-0.094-0.26-0.209-0.367-0.378-0.284-0.471-0.3310.464-0.464
EPS -0.95-0.51-1.12-1.81-0.081-0.088-1.5-0.077-0.140.064-0.062-0.052-0.13-0.1-0.18-0.17-0.12-0.18-0.110.145-0.107
EPS Diluted -0.95-0.51-1.12-1.81-0.081-0.088-1.5-0.077-0.140.044-0.062-0.052-0.13-0.1-0.18-0.17-0.12-0.18-0.110.145-0.107
EBITDA -90.248-73.971-111.447-311.5363.0024.713-249.2983.482-0.1243.869.2898.5624.1663.0631.33611.71512.56711.34213.96611.78211.782
EBITDA Ratio -1.525-1.188-1.778-4.8880.0470.071-3.8160.057-0.0020.0640.1620.1570.0830.0660.0310.2940.340.3370.4640.4320.432